AYTU

Aytu Biopharma Inc

2.635

+0.035+1.35%

Closed16:10 03/30 EDT

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE2.600/2.600

TODAY RANGE2.500-2.660

VOL66.88K

MARKET CAP28.28M

52 WEEK RANGE0.9500-3.065

AVG VOL (3M)78.08K

% TURNOVER0.62%

TURNOVER15.24K

P/E (TTM)-0.7777

% RANGE6.15%

EPS(TTM)-3.3880

P/E(FORWARD)-1.3868

P/B1.992

BVPS1.323

DIVIDEND--

P/S0.3563

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP25.74M

SHARES OUTSTANDING10.73M

NEXT EARNINGS05/12-05/18

FREE FLOAT9.77M

LOT SIZE1

EX-DATE01/06/2023

News

Press Releases

Financial Reports

Profile

Reuters·03/17 21:09
Aytu Biopharma publishes investor presentation on its CNS-focused prescription portfolio and EXXUA for major depressive disorder
TipRanks·02/10 00:20
Aytu BioScience Earnings Call: ExuA Launch vs. Headwinds
TipRanks·02/05 13:20
Analysts Offer Insights on Healthcare Companies: Bio-Techne (TECH) and Aytu BioScience (AYTU)
TipRanks·02/04 14:36
Lake Street Remains a Buy on Aytu BioScience (AYTU)
Seeking Alpha·02/04 01:01
Aytu BioPharma outlines EXXUA launch strategy and expects breakeven at $17.3M quarterly net revenue as ADHD portfolio remains resilient
Reuters·02/03 23:07
Aytu Biopharma stellt neue Unternehmenspräsentation mit Fokus auf Therapien für Depression und ADHS vor
Reuters·02/03 23:07
Aytu Biopharma Inc. unveils new corporate presentation highlighting CNS drug portfolio and strategic realignment
NASDAQ·02/03 22:37
Aytu BioPharma AYTU Q2 2026 Earnings Transcript
TipRanks·02/03 21:50
Aytu BioPharma reports Q2 EPS ($1.05) vs. 13c last year
Seeking Alpha·02/03 21:24
Aytu BioPharma GAAP EPS of -$1.05 misses by $0.45, revenue of $15.2M beats by $3.03M
Reuters·02/03 21:21
Aytu BioPharma Q2 revenue beats expectations
Reuters·02/03 21:06
Aytu Biopharma meldet für das zweite Quartal (Q2) 2026 einen Nettoverlust von USD 10,58 Mio. und einen Rückgang des bereinigten EBITDA um 163 Prozent auf USD -0,80 Mio
Reuters·02/03 21:06
Aytu BioPharma reports Q2 net loss of USD 10.58 million
Reuters·02/03 21:05
AYTU BIOPHARMA Q2 ADJUSTED EBITDA USD -800 THOUSAND
Seeking Alpha·02/03 15:00
Here are the major earnings after the close Tuesday

Same Industry

Name/Symbol

Change%

Price

AYTU

McKesson

MCK

-0.39%

860.16

Biogen Inc

BIIB

-3.78%

183.84

AMGN

Shire

SHPG

0.00%

179.20

CELG-RT

Lilly Eli & Co

LLY

+0.96%

886.63

CELG

TXMD

Johnson & Johnson

JNJ

+0.51%

240.45

Abbvie Inc

ABBV

+1.78%

213.12

ZTS

GILD

Novo-Nordisk A/S

NVO

-0.99%

36.04

Bristol-Myers Squibb Co

BMY

-1.50%

58.54

ALXN

Pfizer

PFE

+2.70%

27.77

Sanofi FR

SNY

+0.34%

46.78

GCVRZ

NVS

Dr Reddys Labs

RDY

-2.11%

13.48

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.